Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Objective Remission Rate”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableLooking for participantsNCT07430579
What this trial is testing

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Who this might be right for
Pathological Complete RemissionObjective Response RateImmune-related Adverse Events+1 more
The Second Hospital of Shandong University 25
Not applicableUnknownNCT04695964
What this trial is testing

Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis

Who this might be right for
Ulcerative ColitisColorectal CancerCrohn Disease+5 more
Charite University, Berlin, Germany 50
Testing effectiveness (Phase 2)Looking for participantsNCT04698785
What this trial is testing

Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Who this might be right for
Bone SarcomaOsteosarcoma
Centre Leon Berard 36
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20